ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 172 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $17,139,000 | -42.0% | 424,018 | -17.5% | 0.01% | -37.5% |
| Q2 2015 | $29,562,000 | -60.5% | 513,675 | -56.3% | 0.01% | -57.9% |
| Q1 2015 | $74,881,000 | +248.0% | 1,176,083 | +237.5% | 0.02% | +216.7% |
| Q4 2014 | $21,517,000 | +940.5% | 348,501 | +554.5% | 0.01% | +500.0% |
| Q3 2014 | $2,068,000 | -86.3% | 53,249 | -87.9% | 0.00% | -75.0% |
| Q2 2014 | $15,119,000 | -37.1% | 438,879 | -21.1% | 0.00% | -42.9% |
| Q1 2014 | $24,043,000 | -7.8% | 556,434 | -15.0% | 0.01% | -12.5% |
| Q4 2013 | $26,086,000 | +316.6% | 654,759 | +292.5% | 0.01% | +300.0% |
| Q3 2013 | $6,262,000 | +299.1% | 166,800 | +185.6% | 0.00% | +100.0% |
| Q2 2013 | $1,569,000 | – | 58,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 5,729,426 | $364,793,000 | 10.87% |
| DOWLING & YAHNKE LLC | 676,323 | $43,061,000 | 5.38% |
| WILLIAM HARRIS INVESTORS INC | 229,887 | $14,638,000 | 3.84% |
| Opus Point Partners Management, LLC | 60,912 | $3,878,000 | 3.25% |
| Nepsis Inc. | 64,580 | $4,112,000 | 2.48% |
| Private Capital Advisors, Inc. | 106,320 | $6,769,000 | 2.46% |
| PINNACLE ASSOCIATES LTD | 1,889,017 | $120,274,000 | 2.24% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 20,947 | $1,333,000 | 1.90% |
| Apex Capital Management | 928,654 | $59,127,000 | 1.39% |
| Bellevue Asset Management AG | 147,000 | $9,359,000 | 1.31% |